Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancers|April 3, 2021
Novel Cytotoxic Chemotherapies in Small Cell Lung CarcinomaDiego Cortinovis, Paolo Bidoli, Stefania Canova, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2014
Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesotheliomaEgesta Lopci, Paolo Andrea Zucali, Giovanni Luca Ceresoli, et al.
Expert Review of Anticancer Therapy|June 21, 2025
Modeling large cell neuroendocrine carcinoma of the lung for molecular, therapeutic and microenvironmental inferences: current knowledge and future perspectivesGiuseppe Pelosi, Maria Gemelli, Fabrizio Bianchi, et al.
Molecular and Cellular Biochemistry|March 16, 2025
Insulin resistance and cancer: molecular links and clinical perspectivesAlfredo Caturano, Enes Erul, Roberto Nilo, et al.
Cancers|April 30, 2021
Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World ExperienceLavinia Monaco, Maria Gemelli, Irene Gotuzzo, et al.
NPJ Precision Oncology|March 6, 2024
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patientsMatteo Villa, Federica Malighetti, Elisa Sala, et al.
Experimental and Molecular Pathology|January 18, 2024
An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasmsGiuseppe Pelosi, Valentina Melocchi, Elisa Dama, et al.
Pathologica|June 27, 2025
Clinical needs and pathology's answers in neuroendocrine neoplasms of the lungGiuseppe Pelosi, Alice Laffi, Mauro Papotti, et al.
Blood Research|August 15, 2020
Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) studyMaria Gemelli, Elena Maria Elli, Chiara Elena, et al.
Expert Review of Anticancer Therapy|November 1, 2025
Pathology, molecular biology, medical oncology, and radiotherapy implications of lung neuroendocrine neoplasm classification: a multidisciplinary perspectiveGiuseppe Pelosi, Alice Laffi, Gianpiero Catalano, et al.
Pageof 3